Manufacturing News of Note: Catalent expands; Hospira and Novartis issue recalls


> Catalent is investing $9 million in a clinical supply facility in San Diego, California. Release

> Nichi-Iko Pharmaceutical, parent of Sagent Pharmaceuticals, says its Canadian subsidiary, Omega Laboratories, has won FDA approval for its site in Montreal to manufacture products for the U.S. Release

> Pfizer's Hospira is voluntarily recalling one lot of bacteriostatic water used to dilute drugs because vials may not be sterile and bring a risk of bacterial infections. Release

> Novartis is recalling one lot of asthma med Xolair in Canada because the vials may include silicone oil. Release

Suggested Articles

GBA offers Brexit escape, Merck and Just - Evotech to share production space, GSK ointment line in Bangladesh may reopen and more news of note.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

Pfizer's Upjohn has reached a deal to exclusively supply generic Viagra to telehealth provider Roman as the company prepares to merge with Mylan.